Week Ending August 1, 2022

Why do people with HIV delay hepatitis C treatment?
“Greater efforts by healthcare providers to build trusting relationships with people with HIV and hepatitis C, together with a greater focus on overcoming concerns about treatment side effects, are likely to be needed to encourage people reluctant to start treatment to taking hepatitis C medication, according to the findings of a US interview study.”

How Do You Get Hepatitis C? Here’s Everything To Know
“Nearly 2.4 million Americans share one thing in common: they’re collectively living with hepatitis C. Though they are faced with the same reality, the stories that illustrate the avenues of contraction aren’t monolithic.”

In young people who inject drugs, a rapid approach to starting treatment for hepatitis C
“A substantial rise in injection drug use among young people in the U.S. has been followed by a significant increase in new hepatitis C virus infections, with cases of acute HCV increasing eight-fold between 2012 and 2019 among people 20-29 years old, according to the Centers for Disease Control and Prevention.”

Viral Hepatitis: What You Need to Know About Risk and Prevention
“It may be one of the least recognized — and most widespread — global health crises. It’s viral hepatitis, and it’s the No. 1 cause of chronic liver disease and other liver-related problems worldwide.”

Impact of direct-acting antiviral treatment of hepatitis C on the quality of life of adults in Ukraine
“Direct-acting antivirals (DAAs) are highly effective in achieving sustained virologic response among those with chronic hepatitis C virus (HCV) infection. Quality of life (QOL) benefits for an HCV-infected population with high numbers of people who inject drugs and people living with HIV (PLHIV) in Eastern Europe have not been explored. We estimated such benefits for Ukraine.”

Direct-acting antivirals can cure hepatitis C and prisons are now leading efforts to eliminate the virus
“While most medical attention has been on COVID, work has been underway to eliminate another viral disease, hepatitis C.”

Nurse-led community hepatitis C testing makes ‘cure more likely’, study finds
“Nurse-delivered community testing and treatment of patients for hepatitis C at community pharmacies made treatment more accessible and a cure more likely, research has found.”

91 million Africans infected with Hepatitis B or C
“More than 91 million Africans live with Hepatitis B or C, which are the deadliest strains of the virus, according to a World Health Organization (WHO) scorecard that launched today – ahead of tomorrow’s World Hepatitis Day.”

Hepatitis C and HIV: Link, Complications, and Treatment
“HCV affects the liver while HIV targets the immune system. Both viruses weaken these body systems over time. The viruses can be contracted and transmitted in similar ways, too, so you can have both types of infection at the same time.”

Testing for hepatitis C could save your life
“If a simple blood test could improve your long-term health or possibly save your life, would you have it performed? The answer for most people is a resounding yes.”

In Conversation: The amazing story of hepatitis C, from discovery to cure
“Despite being one of the fastest viral diseases to be identified and cured by scientists, hepatitis C remains overlooked and underdiagnosed, risking millions of lives.”

Hepatitis C Raises Liver Cancer Risk in Men With Hemophilia, Study Says
“Hepatitis C virus (HCV) infection remains a major risk factor for hepatocellular carcinoma — the most common type of liver cancer — in men with hemophilia, despite the wide availability of medications to fight the virus, a U.S. database analysis has found.”

Methodology for an Adaptable HCV Immunoassay
“Investigators articulated the development and validation of an enzyme-linked immunoassay against hepatitis C virus (HCV). They suggest the implementation of this low cost assay among at-risk populations.”